You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 15, April 20, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Preliminary Communication
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Nutritional and Metabolic Disorders
 •Lipids and Lipid Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Large High-Density Lipoprotein Enriched in Apolipoprotein C-I

A Novel Biochemical Marker in Infants of Lower Birth Weight and Younger Gestational Age

Peter O. Kwiterovich, Jr, MD; Steven L. Cockrill, PhD; Donna G. Virgil, MS; Elizabeth S. Garrett, PhD; James Otvos, PhD; Carolyn Knight-Gibson, MS; Petar Alaupovic, PhD; Trudy Forte, PhD; Lin Zhang, MD, PhD; Zachlyn N. Farwig, PhD; Ronald D. Macfarlane, PhD

JAMA. 2005;293:1891-1899.

Context  Low birth weight is associated with increased cardiovascular disease in adulthood, and differences in the molecular weight, composition, and quantity of lipoprotein subclasses are associated with coronary artery disease.

Objective  To determine if there are novel patterns of lipoprotein heterogeneity in low-birth-weight infants.

Design, Setting, and Participants  Prospective study at a US medical center of a representative sample of infants (n = 163; 70 white and 93 black) born at 28 or more weeks of gestational age between January 3, 2000, and September 27, 2000. This sample constituted 20% of all infants born during the study period at this site.

Main Outcome Measures  Plasma levels and particle sizes of lipoprotein subclasses and plasma concentrations of lipids, lipoproteins (high-density lipoprotein [HDL] and low-density lipoprotein [LDL]), and apolipoproteins.

Results  An elevated lipoprotein peak of a particle with density between 1.062 and 1.072 g/mL was identified using physical-chemical methods. This subclass of large HDL was enriched in apolipoprotein C-I (apo C-I). Based on the amount of the apo C-I–enriched HDL peak, 156 infants were assigned to 1 of 4 groups: 0 (none detected), 17%; 1 (possibly present), 41%; 2 (probably present), 22%; 3 (elevated), 19%. Infants in group 3, compared with those in the other 3 groups, had significantly (P<.001) lower mean birth weight (2683.7 vs 3307.1 g) and younger mean gestational age (36.2 vs 39.3 wk). After correction for age, infants in group 3 had significantly higher levels of total and large HDL cholesterol and of total and large LDL cholesterol and LDL particle number. However, infants in group 3 had lower levels of small HDL, very low-density lipoproteins, and triglycerides than infants in the other 3 groups. This lipoprotein profile differed from that in infants born small for gestational age, who had significantly higher triglyceride (P<.001) and apo B (P = .04) levels, but lower levels of total and large HDL cholesterol (P<.001) and apo A-I (P<.001).

Conclusions  Because apo C-I–enriched HDL, and purified apo C-I alone, promotes apoptosis in vitro, increased amounts of this particle may have physiological significance and identify a novel group of low-birth-weight infants apparently distinct from traditionally classified small-for-gestational-age infants.


Author Affiliations: The Johns Hopkins Medical Institutions, Baltimore, Md (Drs Kwiterovich, Garrett, and Zhang and Ms Virgil); Laboratory for Cardiovascular Chemistry, Texas A & M University, College Station (Drs Cockrill, Farwig, and Macfarlane); LipoScience Inc, Raleigh, NC (Dr Otvos); Oklahoma Medical Research Foundation, Oklahoma City (Dr Alaupovic and Ms Knight-Gibson); and Donner Laboratory, University of California at Berkeley (Dr Forte).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

High-density lipoprotein metabolism and the human embryo
Fujimoto et al.
Hum Reprod Update 2009;0:dmp029v2-dmp029.
ABSTRACT | FULL TEXT  

An HDL Marker of Lower Birth Weight
Journal Watch Cardiology 2005;2005:5-5.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.